Well it looks like the Aspire theorists are probab
Post# of 72440
From the 10Q:
1,400,000 shares sold to Aspire from Oct 1 - Nov 6.
Oct 1 - Nov 6 = 25 trading days
1,400,000/25 = 56,000 shares sold to Aspire per day.
With the low volume we have had, that would certainly help explain the price weakness despite pending B-OM results. I'm glad to see it's not just lack of interest in the stock. Hopefully this is our last tranche of Aspire sales to hold us until a deal. Leo and team wouldn't be raising the money if there wasn't a purpose for it though. More preclinicals? Bolstering cash for negotiations?
Go IPIX!